UCLA CBAM invites you to attend “Targeted Pharmacotherapy to Reduce Substance Use and HIV Risk: Lessons Learned from the Project iN Study,” presented by Glenn-Milo Santos, PhD, MPH on Tuesday, September 23rd.

Dr. Santos is a Research Scientist at the San Francisco Department of Public Health (SFDPH) and an Assistant Professor in the Department of Community Health Systems at University of California, San Francisco. His research foci involves the development of pharmacologic and behavioral interventions to reduce substance use and HIV-related sexual risk behaviors among key populations at risk for HIV, including men who have sex with men, transgender individuals, and people who use drugs.

For more info, email Uyen Kao at ukao@mednet.ucla.edu.

Click here for the flyer, which includes the registration link and more details about the event.


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.